Placebo-Controlled, Double-Blind, Study to Determine the Safety and Efficacy of SDX in Patients With IH
Status:
Recruiting
Trial end date:
2024-01-30
Target enrollment:
Participant gender:
Summary
This is a study of the safety, efficacy and pharmacokinetics (PK) of Serdexmethylphenidate
(SDX) compared to placebo in subjects with Idiopathic Hypersomnia (IH).